Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Analgesics prepared at Ostuka

July 3, 1998

Taisho claims antipsychotic agents devoid of extrapyramidal side effects

July 3, 1998

COX-2 inhibitors for GBS and CIDP

July 3, 1998

EPC-K1 inhibits striatal dopamine release in rat model of ischemia

July 2, 1998

Combination of MS-818 and bFGF enhances neuronal activity

July 2, 1998

U.S. approval for Maxalt

July 2, 1998

Novel monoamine reuptake inhibitor for Parkinson's under investigation at Knoll

July 2, 1998

Potent and selective D4 receptor ligands disclosed by Sumitomo

July 2, 1998

FUB-181 shown to improve learning and memory in mice

July 2, 1998

Angiotech initiates phase I study of paclitaxel for the treatment of multiple sclerosis

July 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...